Robert W. Ashworth
Consejero General en ATYR PHARMA, INC. .
Cargos activos de Robert W. Ashworth
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ATYR PHARMA, INC. | Consejero General | 06/10/2021 | - |
Historial de carrera de Robert W. Ashworth
Antiguos cargos conocidos de Robert W. Ashworth.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Consejero General | 30/07/2018 | - |
| Corporate Officer/Principal | - | 01/09/2021 | |
| AYALA PHARMACEUTICALS, INC. | Oficial de Cumplimiento | 01/01/2015 | 01/01/2018 |
| Consejero General | 01/01/2015 | 01/01/2018 | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Consejero General | - | - |
| NPS PHARMACEUTICALS, INC. | Consejero General | - | - |
Formación de Robert W. Ashworth.
| Massachusetts Institute of Technology | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| General Counsel | 5 |
| Compliance Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| ATYR PHARMA, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Bolsa de valores
- Insiders
- Robert W. Ashworth
- Experiencia
